Lifestyle Interventions for Obesity

(LiveWell Trial)

This trial explores methods to help individuals with obesity or overweight reduce their weight and exposure to endocrine-disrupting chemicals (EDCs). One group will use a digital weight loss program, while the other will focus on reducing EDC exposure through lifestyle changes. The researchers aim to determine which approach more effectively reduces weight and EDC levels. Participants should have a BMI over 25, no certain chronic diseases, and access to a smartphone or computer. As an unphased trial, this study offers participants the chance to contribute to innovative research that could lead to new strategies for managing weight and EDC exposure.

The trial information does not specify whether you need to stop taking your current medications. However, if you are on GLP-1 medications, you cannot participate in the trial.

Research has shown that lifestyle changes, like those tested in this study, can aid in weight loss and health improvement. Studies have found that short-term programs focusing on exercise and healthy eating can lead to weight loss in adults with obesity. For instance, a commercial weight loss program reported that half of its participants lost a significant amount of weight after one year.

Regarding the safety of reducing exposure to endocrine-disrupting chemicals (EDCs), research is ongoing about their effects. These chemicals, found in everyday products, have been linked to health issues such as metabolism problems and weight gain. This trial aims to reduce exposure to these chemicals, which is not known to be harmful.

Researchers are excited about the Lifestyle Interventions for Obesity trial because it explores two innovative approaches to weight management. The Weight Loss Group uses a digital weight loss application, which is a modern, tech-driven method to support people in their weight loss journey. This differs from traditional methods like diet and exercise plans by integrating technology for personalized tracking and feedback. The EDC Reduction Intervention Group focuses on reducing exposure to endocrine-disrupting chemicals, which is a novel angle that considers environmental factors affecting obesity. By addressing these often-overlooked contributors to obesity, the trial could uncover new, holistic strategies for effective weight management.

This trial will compare two approaches for managing weight: a Weight Loss Program and an EDC Reduction Intervention. Studies have shown that short-term programs combining diet and exercise can help people who are overweight or have obesity lose weight. In one study, participants lost an average of 8.6% of their starting weight in a year. Participants in the Weight Loss Group will use a weight loss application for 12 weeks.